CMS May Have Unlikely Ally In Rep. Stark As Interest In ESA Coverage Grows

Rep. Pete Stark, D-Calif., who in the past has been openly critical of how CMS covers erythropoiesis-stimulating agents for Medicare beneficiaries, may be a key ally for the agency as it fends off increased pressure from both Congress and industry stakeholders to reconsider its national coverage determination limiting coverage of ESAs in the non-renal setting